Roswell Biotechnologies, Inc.
Roswell Biotechnologies, Inc., headquartered in the United States, is a pioneering company in the biotechnology sector, specialising in advanced genomic sequencing technologies. Founded in 2016, Roswell has rapidly established itself as a leader in the development of innovative solutions for DNA and RNA analysis, catering to both research and clinical applications. The company’s flagship product, the Roswell Biotechnologies’ platform, offers unique capabilities in high-throughput sequencing, enabling researchers to conduct comprehensive genomic studies with unprecedented accuracy and efficiency. With a commitment to advancing personalised medicine, Roswell Biotechnologies has achieved significant milestones, including collaborations with major research institutions and recognition for its contributions to the field. As a key player in the biotechnology landscape, Roswell Biotechnologies continues to drive innovation, positioning itself at the forefront of genomic research and diagnostics.
DitchCarbon Score
How does Roswell Biotechnologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roswell Biotechnologies, Inc.'s score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roswell Biotechnologies, Inc.'s reported carbon emissions
Roswell Biotechnologies, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that Roswell Biotechnologies may still be in the early stages of developing a comprehensive climate strategy. As the biotechnology industry increasingly prioritises sustainability, it will be essential for Roswell Biotechnologies to establish clear climate commitments and reduction initiatives to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Roswell Biotechnologies, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
